Fig. 5From: The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinomaDisease-Specific Survival (DSS) according to the TP53 mutation status. The 3-year DSS rate of the patients with wild-type TP53, missense TP53 mutation, and truncating TP53 mutation were 94%, 61%, and 43%, respectivelyBack to article page